MINI FUTURE SHORT - MERCK & CO. Stock

Certificat

DE000PE618V3

Delayed Deutsche Boerse AG 04:20:56 2024-05-13 EDT
1.7 EUR +1.19% Intraday chart for MINI FUTURE SHORT - MERCK & CO.
Current month-6.67%
1 month-16.83%
Date Price Change Volume
24-05-13 1.7 +1.19% 0
24-05-10 1.68 -0.59% 0
24-05-09 1.69 -2.87% 0
24-05-08 1.74 +2.35% 0
24-05-07 1.7 -13.27% 0

Delayed Quote Deutsche Boerse AG

Last update May 13, 2024 at 04:20 am

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE618V
ISINDE000PE618V3
Date issued 2022-12-22
Strike 148.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 3.71
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.72
Lowest since issue 1.43
Spread 0.01
Spread %0.58%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW